Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magentiq Eye has developed an AI-powered real-time polyp detection system for use during colonoscopies. Its flagship product, MAGENTIQ COLO™, has been validated in a large international multicenter randomized trial showing a significant increase in adenoma detection rate (+7% absolute; +37% relative) and a substantial reduction in missed adenomas compared to standard procedures. The system received FDA clearance via the 510(k) process in July 2023 and CE Mark approval earlier. Clinical data published in Lancet Digital Health confirm its high sensitivity (~99.6%) and specificity (~98%) for polyp detection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magentiq Eye.